These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 35751003)

  • 21. Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis.
    Brunoni AR; Chaimani A; Moffa AH; Razza LB; Gattaz WF; Daskalakis ZJ; Carvalho AF
    JAMA Psychiatry; 2017 Feb; 74(2):143-152. PubMed ID: 28030740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(5):1-66. PubMed ID: 27099642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Preclinical Study of Standard Versus Accelerated Transcranial Magnetic Stimulation for Depression in Adolescents.
    Seewoo BJ; Hennessy LA; Jaeschke LA; Mackie LA; Etherington SJ; Dunlop SA; Croarkin PE; Rodger J
    J Child Adolesc Psychopharmacol; 2022 Apr; 32(3):187-193. PubMed ID: 34978846
    [No Abstract]   [Full Text] [Related]  

  • 24. Repetitive Transcranial Magnetic Stimulation for Major Depressive Disorder in Older Adults: Systematic Review and Meta-analysis.
    Valiengo L; Maia A; Cotovio G; Gordon PC; Brunoni AR; Forlenza OV; Oliveira-Maia AJ
    J Gerontol A Biol Sci Med Sci; 2022 Apr; 77(4):851-860. PubMed ID: 34432865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bilateral vs. unilateral repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomized controlled trials.
    Chen JJ; Liu Z; Zhu D; Li Q; Zhang H; Huang H; Wei Y; Mu J; Yang D; Xie P
    Psychiatry Res; 2014 Sep; 219(1):51-7. PubMed ID: 24889845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial.
    Borckardt JJ; Nahas ZH; Teal J; Lisanby SH; McDonald WM; Avery D; Durkalski V; Pavlicova M; Long JM; Sackeim HA; George MS
    Brain Stimul; 2013 Nov; 6(6):925-8. PubMed ID: 23769413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials.
    Li H; Cui L; Li J; Liu Y; Chen Y
    J Affect Disord; 2021 May; 287():115-124. PubMed ID: 33780827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
    Avery DH; Isenberg KE; Sampson SM; Janicak PG; Lisanby SH; Maixner DF; Loo C; Thase ME; Demitrack MA; George MS
    J Clin Psychiatry; 2008 Mar; 69(3):441-51. PubMed ID: 18294022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization and outcomes of transcranial magnetic stimulation and usual care for MDD in a large group psychiatric practice.
    Bastiaens J; Brown N; Bermudes RA; Juusola JL; Bravata DM; Marton TF
    BMC Psychiatry; 2024 Jul; 24(1):497. PubMed ID: 38982458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder and Major Depression: Comparing Commonly Used Clinical Protocols.
    Philip NS; Doherty RA; Faucher C; Aiken E; van 't Wout-Frank M
    J Trauma Stress; 2022 Feb; 35(1):101-108. PubMed ID: 33973681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Repetitive transcranial magnetic stimulation in major depression: response factor].
    Dumas R; Padovani R; Richieri R; Lançon C
    Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blinding integrity in randomized sham-controlled trials of repetitive transcranial magnetic stimulation for major depression: a systematic review and meta-analysis.
    Berlim MT; Broadbent HJ; Van den Eynde F
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):1173-81. PubMed ID: 23399312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
    Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
    J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial.
    Croarkin PE; Elmaadawi AZ; Aaronson ST; Schrodt GR; Holbert RC; Verdoliva S; Heart KL; Demitrack MA; Strawn JR
    Neuropsychopharmacology; 2021 Jan; 46(2):462-469. PubMed ID: 32919400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deep transcranial magnetic stimulation (DTMS) in the treatment of major depression: An exploratory systematic review and meta-analysis.
    Kedzior KK; Gellersen HM; Brachetti AK; Berlim MT
    J Affect Disord; 2015 Nov; 187():73-83. PubMed ID: 26321258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression.
    Leuchter AF; Cook IA; Feifel D; Goethe JW; Husain M; Carpenter LL; Thase ME; Krystal AD; Philip NS; Bhati MT; Burke WJ; Howland RH; Sheline YI; Aaronson ST; Iosifescu DV; O'Reardon JP; Gilmer WS; Jain R; Burgoyne KS; Phillips B; Manberg PJ; Massaro J; Hunter AM; Lisanby SH; George MS
    Brain Stimul; 2015; 8(4):787-94. PubMed ID: 26143022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study.
    Harel EV; Rabany L; Deutsch L; Bloch Y; Zangen A; Levkovitz Y
    World J Biol Psychiatry; 2014 May; 15(4):298-306. PubMed ID: 22313023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient Outcomes in Disorders of Consciousness Following Transcranial Magnetic Stimulation: A Systematic Review and Meta-Analysis of Individual Patient Data.
    O'Neal CM; Schroeder LN; Wells AA; Chen S; Stephens TM; Glenn CA; Conner AK
    Front Neurol; 2021; 12():694970. PubMed ID: 34475848
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of machine learning in predicting clinical response to transcranial magnetic stimulation in comorbid posttraumatic stress disorder and major depression: A resting state electroencephalography study.
    Zandvakili A; Philip NS; Jones SR; Tyrka AR; Greenberg BD; Carpenter LL
    J Affect Disord; 2019 Jun; 252():47-54. PubMed ID: 30978624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility and clinical effects of theta burst stimulation in youth with major depressive disorders: An open-label trial.
    Dhami P; Knyahnytska Y; Atluri S; Lee J; Courtney DB; Croarkin PE; Blumberger DM; Daskalakis ZJ; Farzan F
    J Affect Disord; 2019 Nov; 258():66-73. PubMed ID: 31398593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.